ARAY – Accuray Incorporated

Accuray Incorporated

ARAY

$1.60

Name : Accuray Incorporated

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $164,529,600.00

EPSttm : -0.04

Accuray Incorporated

$1.60

5.36%

$0.09

Float Short %

4.63

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

0.04

EPS Last/This Y

0.14

EPS This/Next Y

0.12

Price

1.7

Target Price

6.12

Analyst Recom

Performance Q

-14.65

Relative Volume

1.87

Beta

1.29

Ticker: ARAY

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-05	ARAY	1.915	0.05	0.00	7856
2025-03-06	ARAY	1.835	0.05	0.00	7913
2025-03-07	ARAY	1.86	0.04	0.00	7863
2025-03-10	ARAY	1.79	0.04	0.03	7787
2025-03-11	ARAY	1.81	0.04	1.11	7929
2025-03-12	ARAY	1.825	0.03	0.00	7920
2025-03-13	ARAY	1.74	0.03	0.00	7950
2025-03-14	ARAY	1.83	0.03	3.33	7956
2025-03-17	ARAY	1.87	0.03	0.00	7970
2025-03-18	ARAY	1.815	0.03	0.00	8075
2025-03-19	ARAY	1.875	0.03	0.00	8091
2025-03-20	ARAY	1.845	0.03	0.00	8090
2025-03-21	ARAY	1.86	0.03	0.00	8094
2025-03-24	ARAY	1.9	0.06	0.00	4124
2025-03-25	ARAY	1.9	0.06	0.00	4110
2025-03-26	ARAY	1.87	0.06	0.00	4114
2025-03-27	ARAY	1.885	0.06	0.22	4114
2025-03-28	ARAY	1.825	0.06	0.22	4114
2025-03-31	ARAY	1.795	0.06	0.08	4123
2025-04-01	ARAY	1.785	0.06	0.00	4201
2025-04-02	ARAY	1.815	0.06	0.89	4210
2025-04-03	ARAY	1.7	0.06	0.12	4220
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-05	ARAY	1.92	11.1	-	-0.02
2025-03-06	ARAY	1.83	11.1	-	-0.02
2025-03-07	ARAY	1.86	11.1	-	-0.02
2025-03-10	ARAY	1.79	11.1	-	-0.02
2025-03-11	ARAY	1.81	11.1	-	-0.02
2025-03-12	ARAY	1.82	11.1	-	-0.02
2025-03-13	ARAY	1.74	11.1	-	-0.02
2025-03-14	ARAY	1.83	11.1	-	-0.02
2025-03-17	ARAY	1.87	11.1	-	-0.02
2025-03-18	ARAY	1.81	11.1	-	-0.02
2025-03-19	ARAY	1.87	11.1	-	-0.02
2025-03-20	ARAY	1.85	11.1	-	-0.02
2025-03-21	ARAY	1.86	11.1	-	-0.02
2025-03-24	ARAY	1.90	11.1	-	-0.02
2025-03-25	ARAY	1.90	11.1	-	-0.02
2025-03-26	ARAY	1.87	11.1	-	-0.02
2025-03-27	ARAY	1.89	11.1	-	-0.02
2025-03-28	ARAY	1.82	11.1	-	-0.02
2025-03-31	ARAY	1.79	11.1	-	-0.02
2025-04-01	ARAY	1.78	11.1	-	-0.02
2025-04-02	ARAY	1.82	11.1	-	-0.02
2025-04-03	ARAY	1.70	11.1	-	-0.02
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-05	ARAY	-0.16	-0.32	4.29
2025-03-06	ARAY	-0.16	-0.32	4.29
2025-03-07	ARAY	0.00	-0.32	4.29
2025-03-10	ARAY	0.00	-0.45	4.29
2025-03-11	ARAY	0.00	-0.45	4.29
2025-03-12	ARAY	0.00	-0.45	4.40
2025-03-13	ARAY	0.00	-0.45	4.40
2025-03-14	ARAY	0.00	-0.45	4.39
2025-03-17	ARAY	0.00	-0.46	4.39
2025-03-18	ARAY	0.00	-0.46	4.39
2025-03-19	ARAY	0.00	-0.46	4.39
2025-03-20	ARAY	0.00	-0.46	4.39
2025-03-21	ARAY	0.00	-0.46	4.39
2025-03-24	ARAY	0.00	-0.46	4.39
2025-03-25	ARAY	0.00	-0.46	4.39
2025-03-26	ARAY	0.00	-0.46	4.63
2025-03-27	ARAY	0.00	-0.46	4.63
2025-03-28	ARAY	0.00	-0.46	4.63
2025-03-31	ARAY	0.00	-0.53	4.63
2025-04-01	ARAY	0.00	-0.53	4.63
2025-04-02	ARAY	0.00	-0.53	4.63
2025-04-03	ARAY	0.00	-0.53	4.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.02

Avg. EPS Est. Current Quarter

-0.05

Avg. EPS Est. Next Quarter

0.06

Insider Transactions

Institutional Transactions

-0.53

Beta

1.29

Average Sales Estimate Current Quarter

101

Average Sales Estimate Next Quarter

149

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

71.7

Max Drawdown 5-Year %

-76.1

Target Price

6.12

P/E

Forward P/E

17.44

PEG

P/S

0.38

P/B

3.63

P/Free Cash Flow

EPS

-0.05

Average EPS Est. Cur. Y

-0.02

EPS Next Y. (Est.)

0.1

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.96

Relative Volume

1.87

Return on Equity vs Sector %

-28.9

Return on Equity vs Industry %

-27.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

Accuray Incorporated

Sector: Healthcare

Industry: Medical Devices

Employees: 987

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

stock quote shares ARAY – Accuray Incorporated Stock Price stock today

news today ARAY – Accuray Incorporated stock forecast ,stock prediction 2023 2024 2025

marketwatch ARAY – Accuray Incorporated yahoo finance google finance

stock history ARAY – Accuray Incorporated invest stock market

stock prices ARAY premarket after hours

ticker ARAY fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

ARAY – Accuray Incorporated

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ARAY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y